首页 | 本学科首页   官方微博 | 高级检索  
     

99Tcm-MIBI显像对肿瘤多药耐药检测的应用
引用本文:钱习军.99Tcm-MIBI显像对肿瘤多药耐药检测的应用[J].国际放射医学核医学杂志,2002,26(4):173-176.
作者姓名:钱习军
作者单位:东南大学医学院血液肿瘤科
摘    要:MDR(多药耐药)是目前肿瘤化疗失败的主要原因,对MDR的检测可以帮助化疗决策的制定,从而使肿瘤患者得到更有效的治疗。99Tcm-MIBI(99Tcm-甲氧基异丁基异腈)是mdr1基因编码的P-gp(P-糖蛋白)和MRP(多药耐药相关蛋白)的转运底物,肿瘤细胞内99Tcm-MIBI摄取减低表明其P-gp的高表达,并与MRP的表达相关。因此,99Tcm-MIBI显像可在治疗前预测对化疗的反应,并为选择更有效的化疗策略提供依据。99m

关 键 词:多药耐药  99Tcm-甲氧基异丁基异腈  P-糖蛋白  多药耐药相关蛋白  肿瘤
文章编号:1001-098X(2002)04-0173-04
修稿时间:2002年4月24日

The application of 99Tcm-MIBI imaging to detect multidrug resistance
QIAN Xi-jun.The application of 99Tcm-MIBI imaging to detect multidrug resistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(4):173-176.
Authors:QIAN Xi-jun
Abstract:Multidrug resistance is the main cause of chemotherapy failure,To detect multidrug resistance is helpful to develop chemotherapy regimens and more effective treatment of patients with tumors. 99 Tc m -sestamibi is a transport sub-strate of mdr1-encoded P-glycoprotein and MRP.The lower 99 Tc m -sestamibi accumulation indicates the higher expression of P-glycoprotein in tumor cells.Tt is also related to the expression of MRP.As a result,response to chemotherapy can be estimated before starting treatment by means of 99 Tc m -sestamibi imaging and more effective protocol can be chosen.
Keywords:multidrug resistance  99    Tc    m    -sestamibi  P-glycoprotein  multidrug resistance related protein  tumor  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号